PureIR
中文
Menu
About PureIR Game On

Listed Companies

Medical Devices

Consumer Healthcare

Healthcare Technology

Editorial Method

HKEX 02373 · Unpaid pilot profile

Beauty Farm

Beauty Farm Medical and Health Industry Inc.

Beauty Farm operates beauty and wellness, aesthetic medical and subhealth medical services through direct, franchised and managed networks serving women in China’s high-tier cities. In first-half 2026 it reported revenue of RMB1,881.607 million, net profit of RMB239.371 million and a gross margin of 51.4%; at 30 June 2026 it had 706 stores, including 395 direct stores.

Disclosure through2026-06-30 Page reviewed2026-08-30 Listed onHong Kong Stock Exchange
Page two · play it → Official investor-relations website ir@beautyfarm.com.cn Chairman’s statement · 2025 annual report · PDF page 12

This is an unpaid PureIR pilot independently prepared from formal disclosure. The company did not commission or pay for the profile and did not participate in any rating or investment judgement.

A beauty and health network that keeps growing 00

Press and let the service paths grow through the garden

  1. 01Beauty and wellness
  2. 02Aesthetic medical
  3. 03Subhealth medical
  4. 04Members and store network

An editorial metaphor for the disclosed service portfolio and network; it does not represent an individual service or medical outcome.

RMB551.3m Operating cash flow Six months ended 30 June 2026 Approx. RMB2.4bn Cash and cash-like items As at 30 June 2026 706 stores Store network As at 30 June 2026 Continue through the disclosure

Latest formal disclosure

2026 interim results

Formal interim results · unaudited Announcement published 28 August 2026

Interim revenue

RMB1.882bn Up 29.0% year on year; gross profit increased 34.3% to RMB966.535 million. Six months ended 30 June 2026 · RMB million HKEX · PDF page 1

Interim net profit

RMB239.4m Up 40.2% year on year; company-reported non-HKFRS adjusted net profit was RMB262.551 million. Six months ended 30 June 2026 · RMB million HKEX · PDF page 1

Interim operating cash flow

RMB551.3m Net cash generated from operating activities increased 34.4%; the company also disclosed approximately RMB2.4 billion of cash and cash-like items. Six months ended 30 June 2026 · RMB million HKEX · PDF page 21

The figures below are from the formal interim-results announcement for the six months ended 30 June 2026. They are unaudited and were reviewed by the Audit Committee and management; five-year charts continue to use full fiscal years.

Disclosure highlights

Latest disclosed operating scale

Cover of Beauty Farm 2025 annual report
Beauty Farm 2025 annual report · HKEX
01

Company disclosure

Operating cash flow

RMB551.3m

Net cash generated from operating activities increased by 34.4% in first-half 2026.

Period: Six months ended 30 June 2026Currency / unit: RMB millionHKEX PDF page 21
02

Company disclosure

Cash and cash-like items

Approx. RMB2.4bn

The company-disclosed aggregate of cash and cash-like items, up 21.5%; the figure is rounded to the precision disclosed in the announcement.

Period: As at 30 June 2026Currency / unit: RMB millionHKEX PDF page 3
03

Company disclosure

Store network

706 stores

Including 395 direct stores and 311 franchised stores; first-half client visits at direct stores were 1,211,629.

Period: As at 30 June 2026Currency / unit: storesHKEX PDF page 3

Disclosure reading

How the operating model connects

The following is PureIR’s source-linked synthesis of company disclosure, not a rating or forecast.

01

PureIR disclosure synthesis

Dual beauty + dual wellness

In first-half 2026, beauty and wellness, aesthetic medical and subhealth medical services generated RMB1,094.528 million, RMB602.616 million and RMB184.463 million of revenue, forming a one-stop offering from routine services into consumer healthcare.

Type: company disclosure · PDF page 15
02

PureIR disclosure synthesis

Member relationships and value-added services

First-half 2026 client visits at direct stores rose 32.0% to 1,211,629; annualised active members at direct stores reached approximately 220,000 at period-end, up 45.6%.

Type: company disclosure · PDF page 3
03

PureIR disclosure synthesis

Organic growth and industry consolidation

First-half 2026 growth reflected higher direct-store visits and average spending, together with consolidation and integration of Siyanli. Siyanli contributed RMB380 million of consolidated revenue; the figure includes the change in reporting scope from the acquisition.

Type: company disclosure · PDF page 6

Revenue structure

Three services, one client relationship

Beauty and wellness is the largest revenue line and a client entry point. Aesthetic medical and subhealth medical services extend the relationship into consumer healthcare.

Annual series

Revenue by service line

Revenue by service line, unit: RMB million 3,241 2,430 1,620 810 0 20212022202320242025 Beauty & wellness 2021: 1,046.8 RMB million Aesthetic medical 2021: 673.0 RMB million Subhealth medical 2021: 60.9 RMB million Beauty & wellness 2022: 946.7 RMB million Aesthetic medical 2022: 620.2 RMB million Subhealth medical 2022: 68.5 RMB million Beauty & wellness 2023: 1,193.7 RMB million Aesthetic medical 2023: 850.4 RMB million Subhealth medical 2023: 101.0 RMB million Beauty & wellness 2024: 1,443.3 RMB million Aesthetic medical 2024: 927.9 RMB million Subhealth medical 2024: 201.0 RMB million Beauty & wellness 2025: 1,658.0 RMB million Aesthetic medical 2025: 1,016.6 RMB million Subhealth medical 2025: 325.9 RMB million
Period: years ended 31 December; unit：RMB million；type: company disclosure. HKEX 2022 annual report, PDF page 16; HKEX 2023 annual report, PDF page 14; HKEX 2025 annual report, PDF page 27

Definition note: the 2021–2022 filings used “traditional beauty services” and “subhealth assessment and intervention services”; later reports use “beauty and wellness” and “subhealth medical services”.

Five-year disclosure

Scale, profit and margin

The 2025 annual report provides a consistent five-year comparison. Amounts below are RMB million.

Annual series

Revenue and gross profit

Revenue and gross profit, unit: RMB million 3,241 2,430 1,620 810 0 20212022202320242025 Revenue 2021: 1,780.7 RMB million Revenue 2022: 1,635.4 RMB million Revenue 2023: 2,145.1 RMB million Revenue 2024: 2,572.2 RMB million Revenue 2025: 3,000.5 RMB million Gross profit 2021: 833.8 RMB million Gross profit 2022: 717.8 RMB million Gross profit 2023: 977.1 RMB million Gross profit 2024: 1,190.0 RMB million Gross profit 2025: 1,471.9 RMB million
Period: years ended 31 December; unit：RMB million；type: company disclosure. HKEX annual report, PDF page 11

Annual series

Net profit

Net profit, unit: RMB million 367 276 184 92 0 20212022202320242025 Net profit 2021: 208.3 RMB million Net profit 2022: 110.5 RMB million Net profit 2023: 230.1 RMB million Net profit 2024: 252.5 RMB million Net profit 2025: 340.3 RMB million
Period: years ended 31 December; unit：RMB million；type: company disclosure. HKEX annual report, PDF page 11

Annual series

Gross margin

Gross margin, unit: percent 53 40 27 13 0 20212022202320242025 Gross margin 2021: 46.8% Gross margin 2022: 43.9% Gross margin 2023: 45.6% Gross margin 2024: 46.3% Gross margin 2025: 49.1%
Period: years ended 31 December; unit：percent；type: company disclosure. HKEX annual report, PDF page 11

2025 financial position

Operating scale

Stores, visits and active members

Store data are year-end counts. Visits and active members cover direct stores for each full year; several totals are disclosed in rounded form.

Annual series

Store network

Store network, unit: stores 598 449 299 150 0 2022202320242025 Total stores 2022: 378 stores Total stores 2023: 400 stores Total stores 2024: 554 stores Total stores 2025: 550 stores Direct stores 2022: 189 stores Direct stores 2023: 201 stores Direct stores 2024: 275 stores Direct stores 2025: 289 stores
Period: years ended 31 December; unit：stores；type: company disclosure. HKEX 2022 annual report, PDF page 15; HKEX 2023 annual report, PDF page 15; HKEX 2024 annual report, PDF page 14; HKEX 2025 annual report, PDF page 13

Annual series

Direct-store client visits

Direct-store client visits, unit: visits 2,008,800 1,506,600 1,004,400 502,200 0 2022202320242025 Direct-store client visits 2022: 947,274 visits Direct-store client visits 2023: 1,260,000 visits Direct-store client visits 2024: 1,520,000 visits Direct-store client visits 2025: 1,860,000 visits
Period: years ended 31 December; unit：visits；type: company disclosure. HKEX 2022 annual report, PDF page 15; HKEX 2023 annual report, PDF page 15; HKEX 2024 annual report, PDF page 13; HKEX 2025 annual report, PDF page 12

Annual series

Direct-store active members

Direct-store active members, unit: people 166,320 124,740 83,160 41,580 0 2022202320242025 Direct-store active members 2022: 78,318 people Direct-store active members 2023: 94,000 people Direct-store active members 2024: 137,027 people Direct-store active members 2025: 154,000 people
Period: years ended 31 December; unit：people；type: company disclosure. HKEX 2022 annual report, PDF page 15; HKEX 2023 annual report, PDF page 15; HKEX 2024 annual report, PDF page 13; HKEX 2025 annual report, PDF page 12

Leadership profile

Senior management

The 2025 annual report identifies four members of senior management. Three portraits are sourced from the official investor-relations website; no official portrait was located for the COO.

Official portrait of Li Yang

Company disclosure

Li Yang

Chairman of the Board and Executive Director

Joined the Group in 2003 and is responsible for overall management, business, strategy, and oversight of commercial suitability and sustainability; previously held senior roles at Hainan provincial development, real-estate and state-asset bodies.

Official portrait: company IR website

Type: company disclosure · PDF page 40
1 / 4

Official market reference

Latest market information

PureIR does not display or redistribute market-price data. View 02373 on HKEX’s official securities quote page.

View 02373 quote on HKEX This link leaves PureIR. Market data and applicable terms are provided and managed by HKEX.

Formal disclosure

Principal risks and uncertainties

01

Brand reputation and client disputes

The company discloses that negative brand perception and client complaints, claims or legal proceedings arising in ordinary operations may adversely affect the business.

Type: company disclosure · PDF page 84
02

Medical and industry regulation

The company must continue to obtain and renew relevant permits, licences and filings; regulatory reform may introduce stricter requirements, additional expense or penalties.

Type: company disclosure · PDF page 84
03

Prepaid-card and franchise exposure

Tighter regulation of prepaid-card and franchise activities may reduce cash flow, increase safeguarded funds and create exposure to liabilities owed to franchisees’ customers.

Type: company disclosure · PDF page 84
04

Acquisition goodwill and contractual arrangements

Goodwill or intangible assets arising from acquisitions may be impaired; parts of the business rely on contractual arrangements whose control effectiveness, tax treatment and regulatory interpretation remain uncertain.

Type: company disclosure · PDF page 97

Evidence

Formal sources and public data

The page uses HKEX annual reports, formal shareholder-return announcements and the company’s official investor-relations website. The public JSON contains page-level source metadata, not full filing text.

2025 Annual Report2026-04-27 · 286 PDF pages2024 Annual Report2025-04-24 · 266 PDF pages2023 Annual Report2024-04-24 · 258 PDF pages2022 Annual Report2023-04-24 · 366 PDF pages Interim results for the six months ended 30 June 20262026-08-28 · 49 PDF pages · Formal announcementShareholder Return Plan for the Next Three Years2025-11-04 · 2 PDF pages · Formal announcementPoll Results of the Annual General Meeting2026-06-26 · 4 PDF pages · Formal announcementNext Day Disclosure Return2026-07-15 · 7 PDF pages · Formal announcement

PureIR is an independent, unofficial information platform and does not represent Beauty Farm. This page is not investment advice and provides no rating, target price or undisclosed forecast.